Central thromboxane receptors: mRNA expression and mediation of pressor responses.

These studies tested whether activation of central thromboxane (Tx)A2/prostaglandin (PG) H2 receptors raises blood pressure (BP). Messenger RNA for TxA2/PGH2 receptors was detected in normal Sprague-Dawley rat brain and in rat neuronal and astroglial brain cells in culture. The mean arterial blood pressure (MAP) was recorded in conscious rats during graded administration of the TxA2/PGH2 receptor agonist U-46,619 given intracerebroventricularly or intravenously. Because the pressor responses to intracerebroventricular (but not intravenous) U-46,619 were significantly greater in-high-salt compared with low-salt rats, high-salt rats were used for subsequent studies. The rise in MAP with intracerebroventricular administration of U-46,619 was greater than with intravenous administration and was more sustained. A comparison of plasma radioactivity after intracerebroventricular or intravenous injection of [3H]U-46,619 demonstrated that approximately 35% of the drug reached the systemic circulation by 5-15 min after intracerebroventricular administration. Coadministration of a TxA2/PGH2 antagonist, ifetroban, by intravenous or intracerebroventricular routes blocked the pressor responses induced by U-46,619. The half-maximal inhibition for blockade of responses was substantially lower for intracerebroventricular than for intravenous responses (intracerebroventricular: 0.03 +/- 0.01 vs. intravenous: 3.1 +/- 0.6 micrograms/kg; P < 0.001). The intravenous administration of ifetroban (10 micrograms/kg) caused a greater (P < 0.02) inhibition of pressor responses to U-46,619 (1 microgram/kg) given intravenously (81 +/- 3%) compared with U-46,619 given intracerebroventricularly (40 +/- 13%). In conclusion, TxA2/PGH2 receptor mRNA is expressed in neurons, glial, and brain stem of normal rats. The central administration of a TxA2/PGH2 mimetic raises blood pressure by interaction with specific central and peripheral receptors. This response is augmented in rats fed a high-salt compared with a low-salt diet.

[1]  Y. Taniyama,et al.  Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization. , 1995, The Journal of clinical investigation.

[2]  W. Beierwaltes,et al.  Endothelium-derived constricting factor in renovascular hypertension. , 1995, Hypertension.

[3]  T. Marunouchi,et al.  cDNA cloning of a thromboxane A2 receptor from rat astrocytes. , 1995, Biochimica et biophysica acta.

[4]  J. Sassard,et al.  Thromboxane A2-prostaglandin H2 and renovascular hypertension in rats. , 1994, The American journal of physiology.

[5]  W. Welch,et al.  Renal vasoconstriction with U-46,619; role of arachidonate metabolites. , 1994, Journal of the American Society of Nephrology : JASN.

[6]  J. Nakamoto,et al.  A method for isolation of rat renal microvessels and mRNA localization. , 1994, The American journal of physiology.

[7]  R. McCarron,et al.  Prostaglandin D2 and endothelin-1 induce the production of prostaglandin F2α, 9 α, 11β-prostaglandin F2, prostaglandin E2, and thromboxane in capillary endothelium of human brain , 1993 .

[8]  M. Webb,et al.  Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist. , 1993, The Journal of pharmacology and experimental therapeutics.

[9]  P. Halushka,et al.  Characterization of rat glomerular thromboxane A2 receptors: comparison to rat platelets. , 1992, European journal of pharmacology.

[10]  N. Nakahata,et al.  The presence of thromboxane A2 receptors in cultured astrocytes from rabbit brain , 1992, Brain Research.

[11]  W. Welch,et al.  Potentiation of tubuloglomerular feedback in the rat by thromboxane mimetic. Role of macula densa. , 1992, The Journal of clinical investigation.

[12]  W. Welch,et al.  Thromboxane mediates renal hemodynamic response to infused angiotensin II. , 1991, Kidney international.

[13]  C. Wilcox,et al.  Response of rat thoracic aortic rings to thromboxane mimetic U-46,619: roles of endothelium-derived relaxing factor and thromboxane A2 release. , 1991, The Journal of pharmacology and experimental therapeutics.

[14]  S. Chemtob,et al.  Changes in cerebrovascular prostaglandins and thromboxane as a function of systemic blood pressure. Cerebral blood flow autoregulation of the newborn. , 1990, Circulation research.

[15]  W. Welch,et al.  Feedback responses during sequential inhibition of angiotensin and thromboxane. , 1990, The American journal of physiology.

[16]  D. Ganten,et al.  Angiotensin‐Induced Hypertension in the Rat Sympathetic Nerve Activity and Prostaglandins , 1989, Hypertension.

[17]  I. Matsuoka,et al.  Thromboxane A2 activates phospholipase C in astrocytoma cells via pertussis toxin-insensitive G-protein. , 1989, European journal of pharmacology.

[18]  F. Coceani,et al.  Prostaglandin formation in the hypothalamus in vivo: effect of pyrogens. , 1989, The American journal of physiology.

[19]  W. Welch,et al.  Modulating role for thromboxane in the tubuloglomerular feedback response in the rat. , 1988, The Journal of clinical investigation.

[20]  A. Faden,et al.  Traumatic spinal cord injury in rats causes increases in tissue thromboxane but not peptidoleukotrienes , 1988, Journal of neuroscience research.

[21]  A. Seregi,et al.  Are cerebral prostanoids of astroglial origin? Studies on the prostanoid forming system in developing rat brain and primary cultures of rat astrocytes , 1987, Brain Research.

[22]  S. Klahr,et al.  Thromboxane synthesis and blood pressure in spontaneously hypertensive rats. , 1986, Hypertension.

[23]  E. Jackson.  Effects of thromboxane synthase inhibition on vascular responsiveness in the in vivo rat mesentery. , 1985, The Journal of clinical investigation.

[24]  A. Sirén,et al.  Central cardiovascular effects of the endoperoxide analogue U-46619 in rats. , 1985, Prostaglandins, leukotrienes, and medicine.

[25]  D. Brooks,et al.  Central indomethacin enhances volume-dependent vasopressin release. , 1984, The American journal of physiology.

[26]  R. Jackisch,et al.  Comparison of the prostanoid synthesizing capacity in homogenates from primary neuronal and astroglial cell cultures. , 1984, Biochemical pharmacology.

[27]  E. Shohami,et al.  The effect of incomplete cerebral ischemia on prostaglandin levels in rat brain. , 1982, Stroke.

[28]  J. Hallenbeck,et al.  Prostaglandin I2 and Indomethacin Prevent Impairment of Post‐Ischemic Brain Reperfusion in the Dog , 1979, Stroke.